mRNA vaccine targeting spike protein (Shanghai RNACure Biopharma/Shanghai Jiao Tong University/Fudan University)

N/A

Report date: 2025/12/12 17:32:34

Base Information

Drug NamemRNA vaccine targeting spike protein (Shanghai RNACure Biopharma/Shanghai Jiao Tong University/Fudan University)
Drug Alias NameCOVID-19 mRNA vaccine targeting S-RBD (Shanghai RNACure Biopharma/Shanghai Jiao Tong University/Fudan University)COVID-19 mRNA vaccine targeting S-RBD (Shanghai RNACure Biopharma/Shanghai Jiao Tong University/Fudan University)mRNA vaccine targeting spike protein (Shanghai RNACure Biopharma/Shanghai Jiao Tong University/Fudan University)mRNA vaccine targeting spike protein (Shanghai RNACure Biopharma/Shanghai Jiao Tong University/Fudan University)SARS-CoV-2 mRNA vaccine targeting S-RBD (Shanghai RNACure Biopharma/Shanghai Jiao Tong University/Fudan University)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Rnacure Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Rnacure Biopharma Co LtdFudan UniversityShanghai Jiaotong University
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A